These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28195322)

  • 1. Generalised pustular psoriasis and neutrophilic cholangitis: An infrequently reported association with excellent response to tumour necrosis factor inhibitors.
    Rodríguez-Lomba E; Baniandrés O; Cano N; Suárez-Fernández R
    Australas J Dermatol; 2017 Feb; 58(1):70-71. PubMed ID: 28195322
    [No Abstract]   [Full Text] [Related]  

  • 2. A dramatic response to a single dose of infliximab as rescue therapy in acute generalized pustular psoriasis of von Zumbusch associated with a neutrophilic cholangitis.
    Chandran NS; Chong WS
    Australas J Dermatol; 2010 Feb; 51(1):29-31. PubMed ID: 20148838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis.
    Ovejero-Benito MC; Cabaleiro T; Sanz-García A; Llamas-Velasco M; Saiz-Rodríguez M; Prieto-Pérez R; Talegón M; Román M; Ochoa D; Reolid A; Daudén E; Abad-Santos F
    Br J Dermatol; 2018 Mar; 178(3):798-800. PubMed ID: 28369750
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
    PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ustekinumab in patients previously treated with TNFα inhibitors: a real-life study.
    Pinheiro RR; Duarte B; Ferreira A; Cabete J
    Eur J Dermatol; 2018 Feb; 28(1):89-91. PubMed ID: 29400282
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence of antidrug antibodies correlates inversely with the plasma tumor necrosis factor (TNF)-α level and the efficacy of TNF-inhibitor therapy in psoriasis.
    Kui R; Gál B; Gaál M; Kiss M; Kemény L; Gyulai R
    J Dermatol; 2016 Sep; 43(9):1018-23. PubMed ID: 26892625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug survival of biologic treatments in psoriasis: a systematic review.
    No DJ; Inkeles MS; Amin M; Wu JJ
    J Dermatolog Treat; 2018 Aug; 29(5):460-466. PubMed ID: 29076754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C; Marshman G; Grillo M; Stanford T
    Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor Inhibitor Primary Failure Predicts Decreased Ustekinumab Efficacy in Psoriasis Patients.
    Sorensen EP; Fanucci KA; Saraiya A; Volf E; Au SC; Argobi Y; Mansfield R; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):893-8. PubMed ID: 26267736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic drug survival in Israeli psoriasis patients.
    Shalom G; Cohen AD; Ziv M; Eran CB; Feldhamer I; Freud T; Berman E; Oren S; Hodak E; Pavlovsky L
    J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.
    Esposito M; Gisondi P; Cassano N; Ferrucci G; Del Giglio M; Loconsole F; Giunta A; Vena GA; Chimenti S; Girolomoni G
    Br J Dermatol; 2013 Sep; 169(3):666-72. PubMed ID: 23647206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate.
    Wu JJ; Guérin A; Sundaram M; Dea K; Cloutier M; Mulani P
    J Am Acad Dermatol; 2017 Jan; 76(1):81-90. PubMed ID: 27894789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study.
    Shaaban D; Al-Mutairi N
    J Dermatolog Treat; 2018 Feb; 29(1):3-7. PubMed ID: 27881030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis.
    Jacobi A; Rustenbach SJ; Augustin M
    Int J Dermatol; 2016 Mar; 55(3):296-302. PubMed ID: 26470689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocytic nevus count and dermoscopic features do not differ in psoriatic patients undergoing biological agent versus conventional drug therapy.
    Pirmit S; Onsun N; Su O; Ozkaya DB
    G Ital Dermatol Venereol; 2017 Apr; 152(2):126-131. PubMed ID: 28166613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dramatic response to a single dose of infliximab in a patient with prolonged pustular psoriasis derived from inverse psoriasis.
    Li M; Dai W; Yan W; Liu Y; Wang L; Li W
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28419647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked decrease in serum squamous cell carcinoma antigen level after antitumor necrosis factor alpha therapy in six cases of severe psoriasis.
    Iriki H; Tanese K; Furuichi Y; Takeshita K; Saito M
    Int J Dermatol; 2016 Jun; 55(6):e364-6. PubMed ID: 26696364
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports.
    Lu J; Li Y; Yu N; Chen F; Ding Y; Yi X
    J Int Med Res; 2020 Mar; 48(3):300060520912091. PubMed ID: 32216562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.
    Tragiannidis A; Kyriakidis I; Zündorf I; Groll AH
    Mycoses; 2017 Apr; 60(4):222-229. PubMed ID: 27766695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept.
    Poulin Y
    J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.